Japan Urinalysis Market (2024-2029)
The Japan Urinalysis Market was valued at $194.9 Million in 2024 and projected to reach to $345.3 Million by 2029, representing a compound annual growth rate of 12.1%. Japan's urinalysis market is poised for sustained expansion driven by demographic shifts and healthcare modernization.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan Urinalysis Market Trends and Insights
- This 12.1% compound annual growth rate reflects Japan's aging population and increasing prevalence of chronic diseases requiring routine diagnostic screening.
- Japan's advanced healthcare infrastructure and high adoption of automated urinalysis systems are driving market expansion across hospitals, diagnostic laboratories, and point-of-care settings. The Japanese urinalysis market benefits from strong government healthcare spending and a well-established reimbursement framework that supports diagnostic testing.
- Japan's emphasis on preventive medicine and early disease detection has accelerated demand for urinalysis as a routine screening tool.
- Between 2024 and 2029, Japan is expected to see significant investment in laboratory automation and digital pathology solutions, positioning the country as a key growth market within the Asia Pacific region..
Key Market Statistics
- CAGR (2024-2029) 12.1% CAGR
- Market Size, 2024 ~USD 194.9 Million
- Forecast, 2029 ~USD 345.3 Million
- Country Japan
Japan Urinalysis Market Overview
Market Valuation & Growth :
Japan's urinalysis market is valued at $194.9 million in 2024, with a robust 12.1% CAGR projected through 2029, reaching $345.3 million. This growth rate significantly outpaces the global average of 9.6%, reflecting Japan's unique market dynamics.
Aging Population Driver :
Japan's rapidly aging demographic, with over 29% of the population aged 65+, is driving increased demand for routine diagnostic screening and chronic disease monitoring through urinalysis testing.
Advanced Healthcare Infrastructure :
Japan's sophisticated healthcare system and high adoption of automated urinalysis systems position the country as a leader in diagnostic innovation, with widespread integration across hospitals, clinics, and diagnostic centers.
Chronic Disease Prevalence :
Rising incidence of diabetes, hypertension, and kidney disease in Japan necessitates regular urinalysis screening, creating sustained demand for both laboratory equipment and consumables in the diagnostic sector.
Japan Urinalysis Market Dynamics
- The aging population's increased healthcare utilization, combined with Japan's emphasis on preventive medicine and early disease detection, creates a favorable environment for market growth.
- Healthcare providers are increasingly investing in automated urinalysis systems to improve efficiency and diagnostic accuracy. Looking ahead to 2029, Japan's market will benefit from technological advancements in point-of-care testing and digital health integration.
- Government healthcare initiatives supporting chronic disease management and the rising prevalence of lifestyle-related diseases will further accelerate market penetration.
- The shift toward home-based and remote diagnostic solutions presents additional growth opportunities for market participants..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Japan's urinalysis market is projected to grow from $194.9M (2024) to $345.3M (2029) at a 12.1% CAGR.
- Japan's aging demographic and rising chronic disease prevalence are primary drivers of urinalysis demand.
- Japan's advanced healthcare infrastructure supports high adoption of automated and digital urinalysis technologies.
- Japan's strong reimbursement policies and preventive healthcare focus create favorable market conditions through 2029.
Urinalysis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | HOSPITALS & CLINICS (End User) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 9.6% from 2024 to 2029 |
| Largest Segment | CONSUMABLES (Product) |
| Market Size Base Year (Billions) | ~USD 4.3 (2024) |
| Revenue Forecast (Billions) | ~USD 6.8 (2029) |
| Segments Covered | Product, Type, Test Type, Application, End User |
Japan Urinalysis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Instruments
By Type
- Automated Urine Analyzers
- Biochemical Urine Analyzers
- Brazil
- Diabetes
- Dipsticks
- Disposables
- Flow Cytometry Analyzers
- Integrated Urine Analyzers
- Kidney Diseases
- Laboratory Tests
- Liver Diseases
- Mexico
- Microscopy Analyzers
- Other Disease Screening Applications
- Poc Tests
- Point-Of-Care Urine Analyzers
- Pregnancy & Fertility Kits
- Reagents
- Rest Of Latam
- Sediment Urine Analyzers
- Semi-Automated Urine Analyzers
- Urinary Tract Infections
By Test Type
- Biochemical Tests
- Pregnancy & Fertility Tests
- Sediment Urinalysis
By Application
- Disease Screening
- Pregnancy & Fertility Testing
By End User
- Diagnostic Laboratories
- Home Care Settings
- Hospitals & Clinics
- Research Laboratories & Institutes
JAPAN: URINALYSIS MARKET, BY END USER, 2022–2029
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| DIAGNOSTIC LABORATORIES | 85.8 | 91 | 97.5 | 105.4 | 114.7 | 126.2 | 140.3 | 157.7 | 10.1 |
| HOME CARE SETTINGS | 58.8 | 62.7 | 67.5 | 73.3 | 80.2 | 88.9 | 99.5 | 112.7 | 10.8 |
| HOSPITALS & CLINICS | 70.2 | 77.2 | 85.9 | 96.3 | 109 | 124.7 | 144.3 | 169 | 14.5 |
| RESEARCH LABORATORIES & INSTITUTES | 15.8 | 16.6 | 17.6 | 18.9 | 20.5 | 22.4 | 24.8 | 27.7 | 9.5 |
| TOTAL | 230.6 | 247.4 | 268.5 | 293.9 | 324.3 | 362.2 | 408.9 | 467.1 | 11.7 |
Target Audience
- In Vitro Diagnostics Manufacturers : IVD companies need Japan-specific market data to assess market size, growth potential, and competitive positioning for urinalysis equipment and reagent portfolios in this high-value market.
- Healthcare System Administrators : Hospital and clinic administrators require market insights to optimize diagnostic service offerings, justify capital investments in automated systems, and align with Japan's healthcare modernization trends.
- Medical Device Distributors & Suppliers : Distributors need detailed Japan market analysis to identify growth opportunities, evaluate supplier partnerships, and develop targeted sales strategies for urinalysis products and services.
- Investment & Private Equity Firms : Investors evaluating healthcare opportunities in Japan require comprehensive market data to assess investment potential, identify acquisition targets, and understand growth drivers in the diagnostics sector.
- Healthcare Consultants & Analysts : Consulting firms and research analysts need Japan-specific urinalysis market data to support client advisory work, competitive benchmarking, and strategic planning in the diagnostic healthcare space.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for Japan ($194.9M in 2024) and verified forecasts through 2029, enabling accurate business planning and investment decisions specific to this high-growth market.
- Competitive Landscape Intelligence : Understand Japan's unique competitive dynamics, including local and international players, market share distribution, and strategic positioning within Asia's most advanced healthcare economy.
- Demographic & Clinical Insights : Access detailed analysis of Japan's aging population trends, chronic disease prevalence, and healthcare utilization patterns that directly influence urinalysis demand and market opportunities.
- Technology Adoption Trends : Gain insights into Japan's high adoption rates of automated urinalysis systems, digital health integration, and point-of-care testing innovations shaping the market's future direction.
- Strategic Market Entry & Expansion : Leverage Japan-specific market data to identify growth segments, distribution channels, regulatory requirements, and partnership opportunities for successful market entry or expansion strategies.
Frequently asked questions
What is the current size of Japan's urinalysis market?
Japan's urinalysis market was valued at $194.9 million in 2024 and is expected to reach $345.3 million by 2029.
What is the growth rate of Japan's urinalysis market?
Japan's urinalysis market is growing at a compound annual growth rate (CAGR) of 12.1% from 2024 to 2029.
What factors are driving growth in Japan's urinalysis market?
Key drivers include Japan's aging population, increasing prevalence of chronic diseases, advanced healthcare infrastructure, and strong government support for preventive diagnostic testing.
Which segments are growing fastest in Japan's urinalysis market?
Automated urinalysis systems and point-of-care testing solutions are experiencing the fastest growth in Japan due to increased laboratory efficiency and accessibility demands.
How does Japan's urinalysis market compare to other Asia Pacific countries?
Japan's 12.1% CAGR positions it as a high-growth market within Asia Pacific, driven by superior healthcare infrastructure and higher diagnostic testing adoption rates.
RESEARCH METHODOLOGY
The objective of this study is to analyze the key market dynamics, including drivers, opportunities, constraints, challenges, and strategies employed by key players. Developments within companies, such as acquisitions, product launches, expansions, agreements, and partnerships, will be tracked to assess the competitive landscape of the urinalysis market. This analysis will evaluate market players across various parameters within the broader categories of business and product strategy.
To estimate the market size, both top-down and bottom-up approaches were used. The market breakdown and data triangulation were used to determine the sizes of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources, including annual reports, press releases and investor presentations from companies, white papers, certified publications, articles by recognized authors, gold- and silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva), were consulted to identify and collect information for this study.
Primary Research
In the primary research process, interviews with sources from both the supply and demand sides were conducted to gather qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with key industry participants, subject-matter experts, C-level executives at key market players, and industry consultants to obtain and verify critical qualitative and quantitative information and to assess prospects.
Note 1: Other designations include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
Sysmex Corporation |
Sales Manager |
|
Thermo Fisher Scientific, Inc. |
Sales Executive |
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinalysis market. These methods were also used extensively to estimate the size of various market subsegments. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research.
- The revenue generated by leading players operating in the urinalysis market was determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After determining the overall market size using the process described above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
Urinalysis is a procedure used to assess the appearance, concentration, and content of urine. It detects and helps manage various disorders, such as urinary tract infections, kidney diseases, diabetes, and other metabolic disorders. The primary urinalysis tests include biochemical and sediment analysis. In this report, we have also discussed pregnancy and fertility tests for urine analysis.
Key Stakeholders
- Manufacturers and Distributors of Urinalysis Products
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories & Institutes
- Research & Development (R&D) Companies
- Government Associations
- Venture Capitalists and Investors
Report Objectives
- To define, segment, and forecast the urinalysis market by product, test type, application, technology, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product excellence
- To study the impact of AI on the market, along with the macroeconomic outlook for each region
Available customizations:
MarketsandMarkets offers the following customizations for this market report.
Country Information
- Additional country-level analysis of the urinalysis market
Company profiles
- Additional five company profiles of players operating in the urinalysis market.
Product Analysis
- Product matrix, which provides a detailed comparison of the product portfolio of each company in the urinalysis market
Get the Full Urinalysis Market Report
Full forecast, segment splits, and company analysis for all Urinalysis Market.
- Canada Urinalysis Market
- US Urinalysis Market
- Germany Urinalysis Market
- UK Urinalysis Market
- France Urinalysis Market
- Italy Urinalysis Market
- Spain Urinalysis Market
- Russia Urinalysis Market
- China Urinalysis Market
- India Urinalysis Market
- Australia Urinalysis Market
- South Korea Urinalysis Market
- Brazil Urinalysis Market
- Mexico Urinalysis Market
- Rest Of Europe Urinalysis Market
- Rest Of Asia Pacific Urinalysis Market
- Rest Of Latin America Urinalysis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
